| Firm News

Missouri Government Actions on Covid-19 - Updated 5/6/2020

Today’s update discusses:

  • Pfizer’s St. Louis County facility set to produce new COVID-19 vaccine for clinical trials
  • distribution of the state’s federal funding to local governments
  • Governor encourages residents to shop local

RESOURCES

  • St. Louis County Executive Sam Page announced on Tuesday that Pfizer chose its St. Louis facility to produce a new COVID-19 vaccine for clinical trials. Pfizer is working with a German drug maker, BioNTech, with the first human participants in the United States to receive doses of the vaccine. Pfizer hopes the breadth of the program will allow for production of millions of vaccine doses by the end of the year, and hundreds of millions through next year.
  • During his briefings this week, Governor Parson announced that the state will be distributing funds received through the federal CARES Act to local governments. Under the CARES Act, Missouri received $2.4 billion in federal funding, with $173.5 million going to St. Louis County and $122.7 million to Jackson County. Additionally, 25% of the remaining shares will be distributed to Missouri counties based on population.

 ECONOMY

  • During a recent daily briefing, Governor Parson emphasized the importance of Missouri residents shopping local and supporting Missouri-based businesses. He stated,  “now more than ever, Missouri businesses need [the residents’] support to get back on their feet.” Both Governor Parson and Lieutenant Governor Kehoe discussed the Buy Missouri Program, implemented in 2018, which consists of several Missouri businesses that manufacture or process products in Missouri.  Several members and businesses were highlighted that have provided assistance to manage the COVID-19 outbreak in Missouri by manufacturing hand sanitizer, producing face shields, and donating canned water to first responders.

Attorneys

Jump to Page

HeplerBroom LLC Cookie Preference Center

Your Privacy

When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.

Strictly Necessary Cookies

Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.

Functional Cookies

Always Active

Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information.

Form Submissions

Always Active

When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages.

Performance Cookies

Performance cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.

Powered by Firmseek